Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Oct
14
2014
Protecting Healthcare and Other Employees From Ebola Proskauer Rose LLP
Oct
14
2014
Health Care Law Qui Tam Update: Recent Developments & Unsealed False Claims Act Cases-October 2014 Mintz
Oct
14
2014
Device Advice: New Guidance From the FDA on Medical Devices and Cybersecurity Sheppard, Mullin, Richter & Hampton LLP
Oct
14
2014
Energy and Environmental Law Update - October 13, 2014 Mintz
Oct
14
2014
First Mailbox Appeal to be decided by the Federal Court of Appeals in Brazil Michael Best & Friedrich LLP
Oct
13
2014
New Challenge to 340B Rule Regarding Orphan Drugs McDermott Will & Emery
Oct
13
2014
Health Care Law Update - October 13, 2014 Mintz
Oct
13
2014
Contract Farming in Africa Increases Productivity, Reduces Post-Harvest Loss Covington & Burling LLP
Oct
12
2014
Ninth Circuit Upholds Alameda Safe Drug Disposal Ordinance, Triggering Implementation of King County Secure Medicine Return Rule Beveridge & Diamond PC
Oct
11
2014
Pharmaceutical Research and Manufacturers of America (PhRMA) Filed Suit Today Seeking to Invalidate the 340B Orphan Drug Exclusion Interpretative Rule Covington & Burling LLP
Oct
10
2014
FDA Finalizes Guidance for Management of Cybersecurity in Medical Devices Covington & Burling LLP
Oct
9
2014
Russia: Employers Have Until October 30 to Report Salaries of Highly Qualified Specialists Greenberg Traurig, LLP
Oct
9
2014
FDA Publishes Draft Guidances on Regulatory Framework for Laboratory Developed Tests for Public Comment Covington & Burling LLP
Oct
9
2014
Proposed Rule Issued by HHS Office of the Inspector General (OIG) Realigns Its Enforcement Views with Health Care Reform Goals Mintz
Oct
9
2014
Ebola Response Missing A Critical Player Covington & Burling LLP
Oct
9
2014
Torrent Pharmaceuticals Limited v. Merck Frosst Canada & Co., Denying Institution IPR2014-00559 Faegre Drinker
Oct
8
2014
Land Use By Another Name?: Local California Governments Seek to Tax Softdrinks By Ballot Measure Womble Bond Dickinson (US) LLP
Oct
8
2014
EU Consultation on the Development of Criteria to Identify Endocrine Disruptors in Biocidal and Plant Protection Products Covington & Burling LLP
Oct
7
2014
Office of Inspector General (OIG) Proposes Expanding Anti-Kickback Statute Safe Harbors and Revising Civil Monetary Penalty Regulations McDermott Will & Emery
Oct
7
2014
“The Good Wife” Defends Genetically Modified Organisms (GMOs)
Oct
7
2014
The New Jersey Department of Environmental Protection (NJDEP) Announces New Guidance On “Unrelated Contamination” Giordano, Halleran & Ciesla, P.C.
Oct
7
2014
Health Care Law Update - October 6, 2014 Mintz
Oct
7
2014
Energy and Environmental Law Update - October 6, 2014 Mintz
Oct
7
2014
New Jersey Appellate Division Holds That Applicants for a Professional License Need Not Exhibit an Intent To Deceive In Order To Have Their License Application Denied Due To Misrepresentation Giordano, Halleran & Ciesla, P.C.
Oct
7
2014
Think Twice When Writing About the “Invention” in a Patent Application Mintz
Oct
7
2014
Reclassification of Hydrocodone Takes Effect This Week McBrayer, McGinnis, Leslie and Kirkland, PLLC
Oct
7
2014
Federal Court of Appeals Holds FDA Lacks Authority to Rescind 510(k) Clearance Barnes & Thornburg LLP
Oct
6
2014
FDA Issues Final Guidance on Cybersecurity for Medical Devices Barnes & Thornburg LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins